Case Report
BibTex RIS Cite

Malignant Transformation of Juvenile Nasopharyngeal Angiofibroma in a Non-irradiated Case: A Rarity Denuded

Year 2024, Volume: 7 Issue: 2, 76 - 80, 20.08.2024

Abstract

Nasopharyngeal angiofibroma is a relatively rare tumor, which is locally aggressive and histologically benign with transformation to a malignant sarcomatous form in a previously irradiated candidate.

Here we are reporting the second known case according to literature of a non irradiated case of nasopharyngeal angiofibroma who was previously operated 11 times for the excision of nasopharyngeal angiofibroma. All the previous biopsy reports were proven to be of nasopharyngeal angiofibroma, but for the last time, when he was operated at our center, biopsy showed malignant transformation of nasopharyngeal angiofibroma. The patient was then subjected to intensity modulated radiotherapy and is in close surveillance, doing well till date.

Hence this case presentation gives an insight about malignant transformation of nasopharyngeal angiofibroma in absence of irradiation, which is a very rare entity.

References

  • Hodges JM, McDevitt AS, El-Sayed AI, Sebelik ME. Juvenile nasopharyngeal angiofibroma: current treatment modalities and future considerations. Indian J Otolaryngol Head Neck Surg. 2010;62(3):236-247.
  • Glad H, Vainer B, Buchwald C, et al. Juvenile nasopharyngeal angiofibromas in Denmark 1981-2003: diagnosis, incidence, and treatment. Acta Otolaryngol. 2007;127(3):292-299.
  • Hwang HC, Mills SE, Patterson K, Gown AM. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol. 1998;11(11):1122-1126.
  • Panda S, Rajeshwari M, Singh CA, Sharma SC, Sakthivel P. Radiation-induced sarcoma originating in recurrent juvenile nasopharyngeal angiofibroma. Case Rep Oncol Med. 2018;2018:5695803.
  • Makek MS, Andrews JC, Fisch U. Malignant transformation of a nasopharyngeal angiofibroma. Laryngoscope. 1989;99(10 Pt 1):1088-1092.
  • Donald PJ. Sarcomatous degeneration in a nasopharyngeal angiofibroma. Otolaryngol Head Neck Surg (1979). 1979;1979(87):42-46.
  • Thiagarajan A, Iyer NG. Radiation-induced sarcomas of the head and neck. World J Clin Oncol. 2014;5(5):973-981.
  • Pryor SG, Moore EJ, Kasperbauer JL. Endoscopic versus traditional approaches for excision of juvenile nasopharyngeal angiofibroma. Laryngoscope. 2005;115(7):1201-1207.
  • Frankenthaler R, Ayala AG, Hartwick RW, Goepfert H. Fibrosarcoma of the head and neck. Laryngoscope. 1990;100(8):799-802.
  • Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med. 2005;353(7):701-711.
  • Constantinidou A, Pollack S, Loggers E, Rodler E, Jones RL. The evolution of systemic therapy in sarcoma. Expert Rev Anticancer Ther. 2013;13(2):211-223.
  • Mohebbi S, Aghajanpour M. From juvenile nasopharyngeal angiofibroma to nasopharyngeal carcinoma; A rare case report of nasopharyngeal Mass. Bull Emerg Trauma. 2019;7(4):424-426.
  • Allensworth JJ, Troob SH, Lanciault C, Andersen PE. High-grade malignant transformation of a radiation-naïve nasopharyngeal angiofibroma. Head Neck. 2016;38(suppl 1):E2425-E2427.
  • McAfee WJ, Morris CG, Amdur RJ, Werning JW, Mendenhall WM. Definitive radiotherapy for juvenile nasopharyngeal angiofibroma. Am J Clin Oncol. 2006;29(2):168-170.
  • Cao J, Wang J, He C, Fang M. Angiosarcoma: a review of diagnosis and current treatment. Am J Cancer Res. 2019;9(11):2303-2313.
There are 15 citations in total.

Details

Primary Language English
Subjects Otorhinolaryngology
Journal Section Case Report
Authors

Janakiram T N 0000-0002-7904-0835

Soumya Sampath This is me 0009-0005-4233-3473

Mansi A. R. Venktaramanan This is me 0000-0002-4423-5026

Arunkumar G This is me 0009-0000-5704-9794

Submission Date April 19, 2024
Acceptance Date May 4, 2024
Publication Date August 20, 2024
Published in Issue Year 2024 Volume: 7 Issue: 2

Cite

APA T N, J., Sampath, S., Venktaramanan, M. A. R., G, A. (2024). Malignant Transformation of Juvenile Nasopharyngeal Angiofibroma in a Non-irradiated Case: A Rarity Denuded. European Journal of Rhinology and Allergy, 7(2), 76-80. https://doi.org/10.5152/ejra.2024.24137
AMA T N J, Sampath S, Venktaramanan MAR, G A. Malignant Transformation of Juvenile Nasopharyngeal Angiofibroma in a Non-irradiated Case: A Rarity Denuded. Eur J Rhinol Allergy. August 2024;7(2):76-80. doi:10.5152/ejra.2024.24137
Chicago T N, Janakiram, Soumya Sampath, Mansi A. R. Venktaramanan, and Arunkumar G. “Malignant Transformation of Juvenile Nasopharyngeal Angiofibroma in a Non-Irradiated Case: A Rarity Denuded”. European Journal of Rhinology and Allergy 7, no. 2 (August 2024): 76-80. https://doi.org/10.5152/ejra.2024.24137.
EndNote T N J, Sampath S, Venktaramanan MAR, G A (August 1, 2024) Malignant Transformation of Juvenile Nasopharyngeal Angiofibroma in a Non-irradiated Case: A Rarity Denuded. European Journal of Rhinology and Allergy 7 2 76–80.
IEEE J. T N, S. Sampath, M. A. R. Venktaramanan, and A. G, “Malignant Transformation of Juvenile Nasopharyngeal Angiofibroma in a Non-irradiated Case: A Rarity Denuded”, Eur J Rhinol Allergy, vol. 7, no. 2, pp. 76–80, 2024, doi: 10.5152/ejra.2024.24137.
ISNAD T N, Janakiram et al. “Malignant Transformation of Juvenile Nasopharyngeal Angiofibroma in a Non-Irradiated Case: A Rarity Denuded”. European Journal of Rhinology and Allergy 7/2 (August2024), 76-80. https://doi.org/10.5152/ejra.2024.24137.
JAMA T N J, Sampath S, Venktaramanan MAR, G A. Malignant Transformation of Juvenile Nasopharyngeal Angiofibroma in a Non-irradiated Case: A Rarity Denuded. Eur J Rhinol Allergy. 2024;7:76–80.
MLA T N, Janakiram et al. “Malignant Transformation of Juvenile Nasopharyngeal Angiofibroma in a Non-Irradiated Case: A Rarity Denuded”. European Journal of Rhinology and Allergy, vol. 7, no. 2, 2024, pp. 76-80, doi:10.5152/ejra.2024.24137.
Vancouver T N J, Sampath S, Venktaramanan MAR, G A. Malignant Transformation of Juvenile Nasopharyngeal Angiofibroma in a Non-irradiated Case: A Rarity Denuded. Eur J Rhinol Allergy. 2024;7(2):76-80.

You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104

Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.